KURA ONCOLOGY INC. -

Kura Oncology to Participate in Two Upcoming Investor Conferences

23 May 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Reports First Quarter 2023 Financial Results

10 May 2023 16:03:00 By Nasdaq GlobeNewswire

Kura Oncology to Participate in JMP Securities Life Sciences Conference

09 May 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Report First Quarter 2023 Financial Results

03 May 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Participate in Stifel Targeted Oncology Days

18 Apr 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Reports Preclinical Data Highlighting Synergistic Activity of Farnesyl Transferase Inhibitor in Combination with Targeted Therapies

17 Apr 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Announces Acceptance of Two Abstracts for Presentation at AACR Annual Meeting

14 Mar 2023 17:32:53 By Nasdaq GlobeNewswire

Kura Oncology to Participate in Upcoming Investor Conferences

01 Mar 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Reports Fourth Quarter and Full Year 2022 Financial Results

23 Feb 2023 16:03:00 By Nasdaq GlobeNewswire

Kura Oncology to Report Fourth Quarter and Full Year 2022 Financial Results

16 Feb 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Announces First Patients Dosed in Phase 2 Registration-Directed Trial of Ziftomenib in NPM1-Mutant Acute Myeloid Leukemia

09 Feb 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Participate in SVB Securities Global Biopharma Conference

07 Feb 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Announces FDA Clearance of IND Application for KO-2806, a Next-Generation Farnesyl Transferase Inhibitor

24 Jan 2023 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Presents Updated Clinical Data from KOMET-001 Trial of Menin Inhibitor Ziftomenib at American Society of Hematology Annual Meeting

10 Dec 2022 10:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Host Investor Event on December 10, 2022

01 Dec 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology to Participate in Two Upcoming Investor Conferences

22 Nov 2022 07:30:00 By Nasdaq GlobeNewswire

Kura Oncology Announces Four Abstracts Accepted for Presentation at ASH Annual Meeting

03 Nov 2022 09:01:13 By Nasdaq GlobeNewswire

Kura Oncology Reports Third Quarter 2022 Financial Results

03 Nov 2022 07:30:01 By Nasdaq GlobeNewswire

Kura Oncology Announces Financing Transactions with Bristol Myers Squibb and Hercules Capital, Providing Access to up to $150 Million

03 Nov 2022 07:00:01 By Nasdaq GlobeNewswire

Kura Oncology to Participate in Two Upcoming Investor Conferences

02 Nov 2022 07:30:00 By Nasdaq GlobeNewswire